InvestorsHub Logo
Followers 18
Posts 939
Boards Moderated 0
Alias Born 05/09/2020

Re: Emergcy post# 153301

Wednesday, 03/17/2021 5:19:04 PM

Wednesday, March 17, 2021 5:19:04 PM

Post# of 233152
Understand the point of trial size however when you combine the HIV trials and time the drug has been administered the safety is well demonstrated making up for a 400 patient trial size. There is no excuse for the FDA to creep this along given CD12. Nader also has the responsibility to shareholders to partner and do what is necessary. Imagine if we partnered to fund Covid trials and paid the partner a royalty for the Covid indication. Our LONG term prospects based on all indications would be significantly further along. We will get there but it seems we are taking the tough road.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News